---
title: "Meril GmbH and others v Edwards Lifesciences Corporation (UPC CoA 166/2025, 18-04-2025)"
description: "The Court of Appeal refused Meril's request to suspend the Munich Local Division's infringement decision in favour of Edwards Lifesciences pending Meril's…"
url: https://pitch.law/academy/upc-court-of-appeal/upc-coa-166-2025-2025-04-18
lang: en
author: "UPC Case Law by Pitch"
editor: "Bart Lieben"
datePublished: 2026-11-18T10:07:21.211Z
dateModified: 2026-11-18T10:07:21.211Z
---

# Meril GmbH and others v Edwards Lifesciences Corporation

Order of the UPC Court of Appeal of 18 April 2025, UPC CoA 166/2025.

UPC Case Law by Pitch, edited by [Bart Lieben](https://pitch.law/team/bart-lieben) · Published 18-11-2026

## TL;DR

The Court of Appeal refused Meril's request to suspend the Munich Local Division's infringement decision in favour of Edwards Lifesciences pending Meril's appeal. Under Art 74(1) UPCA, a first-instance injunction stays enforceable during the appeal unless exceptional circumstances apply. A pending appeal against the validity decision, economic harm already weighed at first instance, and orders already complied with do not qualify.

## Key holding

Under Art 74(1) UPCA an appeal has no suspensive effect (the first-instance decision is not put on hold pending the appeal) unless the appellant's interest in keeping the status quo exceptionally outweighs the respondent's interest. Examples are a manifestly erroneous decision, meaning findings that are clearly untenable even on a summary assessment, or an appeal that would otherwise become devoid of purpose. A pending appeal against a decision upholding the patent in revocation proceedings is not in itself sufficient. Harm already weighed by the Court of First Instance when granting the orders does not justify suspension unless the decision is manifestly erroneous in that respect.

## Questions decided

1. Does a pending appeal against the validity decision justify suspensive effect in the infringement appeal?
2. What counts as a 'manifest error' for suspensive effect under Art 74(1) UPCA?
3. Is suspensive effect available for orders the appellant has already complied with?
4. Does a respondent's undertaking not to publish defeat the 'devoid of purpose' argument?
5. Do R 223.1 and R 352.1 RoP provide a basis for staying enforcement against security?

## Case details

- Court: Court of Appeal of the Unified Patent Court, Panel 1
- Panel: Klaus Grabinski (President of the Court of Appeal); Peter Blok (legally qualified judge and judge-rapporteur); Emmanuel Gougé (legally qualified judge); Elisabetta Papa (technically qualified judge); Max Tilmann (technically qualified judge)
- Date: 18-04-2025
- Case number(s): UPC CoA 166/2025, UPC CFI 15/2023, UPC CFI 255/2023
- Parties: Applicants/Appellants: Meril GmbH and Meril Life Sciences Pvt Ltd (defendants at first instance); Respondent: Edwards Lifesciences Corporation (claimant at first instance)
- Language of the proceedings: English
- Outcome: The application was rejected, including the alternative request for a stay of enforcement against security.
- Official text on the court’s website (PDF): https://www.unified-patent-court.org/sites/default/files/files/api_order/33064D7BD140C44FAB325502C3E1E8D6_en.pdf

## How to cite

Court of Appeal, Meril GmbH and others v Edwards Lifesciences Corporation, UPC CoA 166/2025, Order of 18 April 2025 (OSCOLA)

## Full summary

Read the full analyses for free — create a free account: https://pitch.law/academy/upc-court-of-appeal/upc-coa-166-2025-2025-04-18

Topics: [Suspensive effect and enforcement](https://pitch.law/academy/upc-court-of-appeal/topics/suspensive-effect-and-enforcement), [Procedure](https://pitch.law/academy/upc-court-of-appeal/topics/procedure)

## In the same case

- [Meril Italy Srl and others v Edwards Lifesciences Corporation, UPC CoA 464/2024, 25-11-2025](https://pitch.law/academy/upc-court-of-appeal/upc-coa-464-2024-2025-11-25): The Court of Appeal upheld EP 3 646 825 as amended by Auxiliary Request II and confirmed that Meril's Myval Octacor heart valve system infringes it.
- [Meril GmbH v Respondent 1 and SWAT Medical AB, UPC CoA 635/2024, 05-05-2025](https://pitch.law/academy/upc-court-of-appeal/upc-coa-635-2024-2025-05-05): The Court of Appeal set aside a Paris Central Division order that had given a European patent attorney and his company access to all pleadings and evidence in a revocation counterclaim.
- [Meril GmbH v SWAT Medical AB and another, UPC CoA 635/2024, 12-02-2025](https://pitch.law/academy/upc-court-of-appeal/upc-coa-635-2024-2025-02-12): A lawyer or European Patent Attorney who is personally a party before the UPC must still be represented by someone else.
- [Meril Life Sciences Pvt. Ltd v Respondent 1 and SWAT Medical AB, UPC CoA 636/2024, 12-02-2025](https://pitch.law/academy/upc-court-of-appeal/upc-coa-636-2024-2025-02-12): A lawyer or European Patent Attorney who is a party before the UPC cannot represent himself and must instruct a separate authorised representative.
- [Meril Italy S.r.l. v SWAT Medical AB and another, UPC CoA 634/2024, 12-02-2025](https://pitch.law/academy/upc-court-of-appeal/upc-coa-634-2024-2025-02-12): A lawyer or European Patent Attorney who is personally a party before the UPC cannot represent themselves.

## More on suspensive effect and enforcement

- [Netflix Services Germany GmbH and others v DivX, LLC, UPC CoA 176/2026, 02-11-2026](https://pitch.law/academy/upc-court-of-appeal/upc-coa-176-2026-2026-11-02): The Court of Appeal refused Netflix's request for suspensive effect against the Munich Local Division's infringement decision in favour of DivX, even though the EPO Opposition Division revoked the patent after that decision.
- [Academy of Military Medical Sciences v Gilead Sciences, Inc., UPC CoA 121/2026, 18-09-2026](https://pitch.law/academy/upc-court-of-appeal/upc-coa-121-2026-2026-09-18): The automatic suspensive effect of an appeal against a revocation decision under Art 74(2) UPCA covers only the ruling on the patent's validity.
- [Fujifilm Corporation v Kodak GmbH and others, UPC CoA 312/2025, 31-08-2026](https://pitch.law/academy/upc-court-of-appeal/upc-coa-312-2025-2026-08-31): The Court of Appeal refused to give suspensive effect to Fujifilm's application for rehearing (Art 81 UPCA) of its own final decision of 2 June 2026.
